1. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 20

    On the scientific value and practical utility of the comparative tests of nicotine-free aerosols in vitro and in vivo

    TROFIMOV A.V.(1); MENSHOV V.A.(1); BERDNIKOVA N.G.(2); YABLONSKAYA O.I.(1)
    (1) Emanuel Institute of Biochemical Physics, RAS, Moscow, Russia; (2) I.M. Sechenov First Moscow State Medical University, Moscow, Russia
    The presence of nicotine in emissions from conventional and electronic cigarettes is an important physiological and associative factor combining these two classes of products. Besides a comparable nicotine delivery, according to other...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 49

    Automation of analytical procedures for mycotoxins, acrylamide, aldehydes and NDMA using Tecan Fluent 1080 automation workstation system

    AVAGYAN R.; BRUNO O.; PATRING J.; LINDHOLM J.
    Swedish Match North Europe AB Europe Division, Stockholm, Sweden
    Mycotoxins, acrylamide, aldehydes and N-nitrosodimethylamine (NDMA) are constituents included on the FDA "Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke: Established List" and considered as large volume analyses at...
  3. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 076

    Nicotine in vivo extraction and pharmacokinetics of non-tobacco-based nicotine pouches (ZYN®) compared with tobacco-based swedish snus and american moist snuff

    STAAF M.; LJUNG T.; PENDRILL R.
    Swedish Match, Stockholm, Sweden
    Objectives • To compare in vivo extracted dose and pharmacokinetics of nicotine from ZYN® with Swedish snus (General) and U.S moist snuff (Longhorn) • To evaluate the effect of the flavor component methyl salicylate on nicotine extraction and uptake...
  4. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 58

    Developing fit-for-purpose self-report instruments for assessing consumer responses to tobacco and nicotine products: the ABOUT Toolbox initiative

    CHREA C.(1); SPIES E.(1); AFOLALU E.F.(1); MAINY N.(1); GALLOT S.(1); BINGGELI P.(1); CLERC E.(1); WEITKUNAT R.(1); SALZBERGER T.(2); CANO S.(3); ACQUADRO C.(4); ARNOULD B.(4); LAMBERT J.(4); BRUNEL V.(4); MARCUCCILLI C.(4); ABETZ-WEBB L.(5); ROSE J.(5); FAGERSTRÖM K.(5)
    (1) Philip Morris Products S.A.(part of Philip Morris International group of companies), Neuchâtel, Switzerland; (2) University of Economics and Business, Vienna, Austria; (3) ScaleReport, Ltd, Stotfold, U.K.; (4) Mapi, an ICON plc Company, Lyon, France; (5) Patient-Centered Outcomes Assessments, Ltd, Macclesfield, Cheshire, U.K.; (6) Rose Research Center, Raleigh, NC, U.S.A.; (7) K. Fagerström Consulting AB, Vaxholm, Sweden
    Assessing the full potential of reduced risk products (RRP), for individual users and the population as a whole, requires the assessment of consumer perception and behavior associated with tobacco and nicotine products (TNP) with different exposure...
  5. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 09

    Oxidation dynamics of e-liquids in electronic nicotine delivery systems with atomisers of various types

    TROFIMOV A.V.; MENSHOV V.A.; YABLONSKAYA O.I.
    Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russian Federation
    The processes of the thermal oxidative destruction of e-liquid components play a key role in the appearance of undesirable products in aerosols generated by electronic nicotine delivery systems (ENDS). The objective of the present studies is to...
  6. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 46

    Analysis of PAHs in smokeless tobacco by GC-MS/MS

    REDEBY J.; MENZEL C.; ANDERSSON K.; GRONOWSKI EDNER A.; LINDHOLM J.
    Swedish Match North Europe AB, Scandinavia Division, Analytical and Product Science, Stockholm, Sweden
    Polycyclic aromatic hydrocarbons (PAHs) are a large group of compounds; several of which are classified as potentially carcinogenic. Sixteen PAHs are listed on the U.S. Food and Drug Administration (FDA) "Established List for Harmful and Potentially...
  7. CORESTA Congress, Berlin, 2016, Agronomy/Phytopathology Groups, AP 29

    The effects of mycorrhizal fungus on tobacco qualitative and quantitative parameters

    GHORBANIAN D.(1); MASOUDI M.(2)
    (1) British American Tobacco Pars, Tehran, Iran; (2) Iranian Tobacco Company, Tehran, Iran
    To study the impact of Mycorrhizal fungus on flue-cured Virginia tobacco (K326) an experiment was carried out in the Golestan Province of Iran in 2014. The experiment was performed as a complete randomised block design with four replications, the...
  8. CORESTA Congress, Berlin, 2016, Agronomy/Phytopathology Groups, AP 47

    The effects of different planting methods on tobacco quality, yield and yield parameters

    CELEN A.E.; EKREN S.; KOPARAN V.; ILKER E.
    Ege University, Agriculture Faculty, Department of Field Crops, Bornova-Izmir, Turkey
    Tobacco still has great economic importance in the world. Turkey produced 90.000 tonnes of the world’s total tobacco production of 7.3 million tonnes. According to 2013 statistics, 50.877 kg of tobacco, which is more than 50% of the total production...
  9. CORESTA Congress, Berlin, 2016, Smoke Science/Product Technology Groups, ST 08

    Analysis of N-nitrosodimethylamine in smokeless tobacco by use of UHPLC-MS/MS

    ERICSSON D.; PATRING J.; KALVO D.; LINDHOLM J.
    Swedish Match North Europe AB, Stockholm, Sweden
    N-nitrosodimethylamine (NDMA) is a member of the compound group N-nitrosamines and is a carcinogenic substance belonging to IARC Group 2A. In addition, NDMA is on the FDA "Established List for Harmful and Potentially Harmful Constituents in Tobacco...
  10. CORESTA Congress, Berlin, 2016, Smoke Science/Product Technology Groups, ST 09

    Analysis of coumarin in tobacco and smokeless tobacco by use of UHPLC-MS/MS

    PATRING J.; KALVO D.; ERICSSON D.; LINDHOLM J.
    Swedish Match North Europe AB, Stockholm, Sweden
    The demand for chemical analysis is increasing; the number of routine assays is steadily increasing as well as requests for new assays required by the regulators. Coumarin is one of the constituents of regulatory concern on FDA’s established list for...